Profile
ABCM VRTX REGN ALNY SGEN ARGX
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $117.98B $59.32B $43.28B $43.15B $40.50B
Employees 1.76K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABCM VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 4 1 3 4
Quant Rating Sell Buy Strong Sell Neutral Buy
Trading
ABCM VRTX REGN ALNY SGEN ARGX
Last Close $23.99 $366.54 $563 $438.93 $228.74 $661.83
High 52 $23.99 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $23.99 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High 0 % -29.07 % -53.15 % 0 % 0 % -4.13 %
Price vs. 52 Week Low 0 % 0 % 16.58 % 95.44 % 0 % 28.7 %
Total Return
ABCM VRTX REGN ALNY SGEN ARGX
1 Month Return 0 % -23.47 % 1.9 % 36.86 % 0 % 19.21 %
3 Month Return 0 % -13.75 % 6.67 % 74.77 % 0 % 20.41 %
6 Month Return 0 % -21.9 % -20.65 % 58.92 % 0 % 2.35 %
9 Month Return 0 % -29.07 % -32.04 % 58.21 % 0 % 11.05 %
YTD Return 0 % -8.98 % -20.96 % 86.53 % 0 % 7.61 %
1 Year Return 0 % -21.75 % -50.23 % 62.86 % 0 % 23.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
ABCM VRTX REGN ALNY SGEN ARGX
Asset Growth 7.15 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth -34.53 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth -43.19 % 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year 26.28 % 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year 38.49 % 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year 155.91 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth - -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth -135.93 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share -161.73 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share -112.2 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share -122.5 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth -116.16 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) -78.13 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG -58.65 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG -59.52 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG -37.07 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth -135.26 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth -135.6 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share 8.66 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 31.28 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 84.54 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 269.11 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share -9.23 % - - - - -
Dividend 5 Year Growth Per Share 1 % - - - - -
Dividend 10 Year Growth Per Share 72.85 % - - - - -
Debt Growth -2.53 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth -118.55 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ABCM VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 71.21 % 86.03 % 87.44 % 86.01 % 79.1 % 65.32 %
Return on Assets TTM 0.45 % -4.32 % 11.67 % -6.4 % -16.61 % 15.06 %
Return on Equity TTM 0.76 % -6.25 % 14.43 % -509.33 % -20.8 % 18.96 %
Return on Capital Employed TTM 0.8 % -3.89 % 11.12 % -3.68 % -21.46 % 5.04 %
Net Income Per EBT TTM 93.62 % 329.41 % 91.46 % 75.89 % 101.33 % 237.3 %
EBT Per Ebit TTM 73.44 % 40.44 % 126.92 % 308.03 % 98.26 % 147.38 %
EBIT Per Revenue TTM 2.03 % -6.69 % 27.02 % -4.91 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM 27.38 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 1.91
Payables Turnover TTM 7.04 3.49 2.47 3.37 1.97 0.88
Inventory Turnover TTM 1.56 1.14 0.56 5.01 0.96 2.21
Fixed Asset Turnover TTM 195.05 % 421.34 % 293.64 % 337.41 % 665.41 % 5009.77 %
Asset Turnover TTM 31.98 % 48.51 % 37.19 % 55.72 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM 0.3 -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM 0.01 -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 45.81 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM 19.94 % -8.83 % 33.37 % -1.92 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM 27.38 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM - -93.78 15.43 -574.08 -81.26 -521.84
Price To Operating Cash Flows Ratio TTM 40.46 -120.39 12.38 -954.11 -93.1 -618.62
Price Cash Flow Ratio TTM 40.46 -120.39 12.38 -954.11 -93.1 -618.62
Income Statement (TTM)
ABCM VRTX REGN ALNY SGEN ARGX
Revenue $0.36B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.27B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 74.79% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $0.04B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.04 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABCM VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.1B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.33B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.73B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.22B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $1.06B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
ABCM VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $-0.01B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $-0.03B $0B $0B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0.04B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.95
AARD Aardvark Therapeutics, Inc. Common Stock 11.99
ABCL AbCellera Biologics Inc. 4.25
ABEO Abeona Therapeutics Inc. 6.26
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0368
ABSI Absci Corporation 2.84
ABUS Arbutus Biopharma Corporation 3.4
ABVC ABVC BioPharma, Inc. 2.7
ABVX Abivax SA American Depositary Shares 70.13
ACAD ACADIA Pharmaceuticals Inc. 24.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.621
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.5
ACIU AC Immune SA 2.14
ACLX Arcellx, Inc. 70.5
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 132.04
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 41.2
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 50.7955
MNA IQ Merger Arbitrage ETF 6.85 35.525
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 84.43
FPXI First Trust International Equity Opportunities ETF 0.45 56.44
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 39.89
MRGR ProShares Merger ETF 3.16608 42.5
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 31.6686
VINEX Vanguard International Explorer Fund Investor Shares 0.22 20.1
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 70.59
VGHCX Vanguard Health Care Fund Investor Shares 0.36 167.4
BMED BlackRock Future Health ETF 1.68229 24.81
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 22.3738
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 5.568
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.495
DFIC Dimensional International Core Equity 2 ETF 0.00052105 31.78
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.464
CTRU ARK Transparency ETF 0.96 12.897
Unlock